Lilly blows past revenue benchmarks, again raises full-year outlook

Eli Lilly said it reeled in $17.6 billion in third-quarter revenue, beating Wall Street's projected consensus of $16.1 billion. That's a 54% jump compared to the same period in 2024, according ...